Arturo Molina, MD
Chief Medical Officer at Protagonist Therapeutics; Chief Medical Officer at Sutro Biopharma. Based in Newark, California.
- Rank
- 8699th of 14,452
- Companies held
- 2
- Largest holding
- PTGX, 99.7% of total
- Latest SEC filing
- Nov 16, 2026
What the $10.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics PTGX Common Stock | Directly | 81,397 | $124.02 | $10.1M | 99.7% | Form 4, Nov 16, 2026 |
| Sutro Biopharma STRO Common Stock | Directly | 3,774 split-adjusted | $8.72 | $33K | 0.3% | Form 4, Mar 5, 2022 |
Share counts are the amounts Arturo Molina, MD reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sold | PTGX | 2,718 | $124.65 | $339K | View |
| Mar 26, 2026 | Sold | PTGX | 15,000 | $104.79 | $1.6M | View |
| Jan 27, 2026 | Sold | PTGX | 5,000 | $82.00 | $410K | View |
| Jan 26, 2026 | Sold | PTGX | 5,000 | $82.28 | $411K | View |
| Jan 23, 2026 | Sold | PTGX | 13,151 | $82.42 | $1.1M | View |
| Jan 20, 2026 | Sold | PTGX | 9,514 | $82.48 | $785K | View |
| Nov 17, 2025 | Sold | PTGX | 2,712 | $84.77 | $230K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 8696 | Elizabeth S. Campbell Executive Vice President, Cencora. Conshohocken, PA | $10.1M |
| 8697 | Robert T. Webb Director, National Health Investors. Murfreesboro, TN | $10.1M |
| 8698 | Kenneth D. Denman Director, Costco Wholesale. Issaquah, WA | $10.1M |
| 8699 | Arturo Molina, MD Chief Medical Officer, Protagonist Therapeutics. Newark, CA | $10.1M |
| 8700 | Robert Thomas Freeman Chief Financial Officer, Alignment Healthcare. Orange, CA | $10.1M |
| 8701 | Gary Merrill Chief Financial Officer, Commvault Systems. Tinton Falls, NJ | $10.1M |
| 8702 | Eugene A. Delaney Director, Sanmina. San Jose, CA | $10.1M |
Other Protagonist Therapeutics insiders
All PTGX insiders- Dinesh V. Patel, Ph.D$64.9MPresident and CEO. #2116 overall
- Suneel Gupta$33.2MChief Development Officer. #3474 overall
- David Y. Liu$20.8MChief R&D Strategy Officer. #5042 overall
- Harold E. Selick$7.5MDirector. #10796 overall
- Asif Ali$7.3MChief Financial Officer. #11055 overall
Questions
How much stock does Arturo Molina, MD own?
Arturo Molina, MD holds $10,127,762 in listed stock based on SEC filings and current prices, mostly Protagonist Therapeutics (PTGX). That ranks 8699th on the Stock Rich List.
Is this Arturo Molina, MD's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Arturo Molina, MD last buy or sell stock?
The most recent open-market trade on file is a sale of 2,718 PTGX shares on Nov 16, 2026 at $124.65.